Metlife (MET) Receives “Buy” Rating from Keefe, Bruyette & Woods

Keefe, Bruyette & Woods restated their buy rating on shares of Metlife (NYSE:MET) in a report released on Friday morning. The brokerage currently has a $56.00 price objective on the financial services provider’s stock.

A number of other equities research analysts also recently weighed in on MET. Royal Bank of Canada reissued an outperform rating and issued a $60.00 price target (up from $56.00) on shares of Metlife in a report on Friday, November 3rd. Morgan Stanley upped their price target on shares of Metlife from $55.00 to $56.00 and gave the company an equal weight rating in a report on Friday, November 3rd. Argus upped their price target on shares of Metlife from $55.00 to $60.00 and gave the company a buy rating in a report on Monday, November 6th. B. Riley reissued a neutral rating on shares of Metlife in a report on Monday, November 6th. Finally, Zacks Investment Research raised shares of Metlife from a hold rating to a buy rating and set a $60.00 price target for the company in a report on Thursday, November 9th. One equities research analyst has rated the stock with a sell rating, eleven have given a hold rating and nine have issued a buy rating to the company. The stock presently has an average rating of Hold and an average target price of $57.58.

Metlife (MET) traded up $0.84 during mid-day trading on Friday, reaching $47.47. 4,341,881 shares of the company traded hands, compared to its average volume of 8,910,000. The firm has a market capitalization of $49,950.00, a P/E ratio of 11.69, a P/E/G ratio of 0.95 and a beta of 1.31. Metlife has a 1-year low of $43.38 and a 1-year high of $55.91. The company has a quick ratio of 0.16, a current ratio of 0.15 and a debt-to-equity ratio of 0.29.

Metlife (NYSE:MET) last issued its quarterly earnings results on Tuesday, February 13th. The financial services provider reported $0.64 earnings per share for the quarter, missing the Zacks’ consensus estimate of $1.05 by ($0.41). Metlife had a net margin of 5.69% and a return on equity of 8.62%. The business had revenue of $15.79 billion during the quarter, compared to analyst estimates of $15.89 billion. During the same period in the previous year, the company posted $1.28 earnings per share. sell-side analysts expect that Metlife will post 4.93 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 13th. Shareholders of record on Monday, February 5th will be paid a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 3.37%. The ex-dividend date is Friday, February 2nd. Metlife’s dividend payout ratio is presently 39.41%.

A number of hedge funds have recently bought and sold shares of the business. Cowen Prime Services LLC lifted its stake in Metlife by 16.0% during the third quarter. Cowen Prime Services LLC now owns 7,250 shares of the financial services provider’s stock valued at $377,000 after buying an additional 1,000 shares in the last quarter. First National Trust Co. lifted its stake in Metlife by 1.6% during the third quarter. First National Trust Co. now owns 63,661 shares of the financial services provider’s stock valued at $3,307,000 after buying an additional 1,019 shares in the last quarter. Investment Centers of America Inc. lifted its stake in Metlife by 11.6% during the third quarter. Investment Centers of America Inc. now owns 9,874 shares of the financial services provider’s stock valued at $511,000 after buying an additional 1,026 shares in the last quarter. Intrust Bank NA lifted its stake in Metlife by 4.2% during the third quarter. Intrust Bank NA now owns 25,560 shares of the financial services provider’s stock valued at $1,328,000 after buying an additional 1,042 shares in the last quarter. Finally, OLD National Bancorp IN lifted its stake in Metlife by 8.8% during the third quarter. OLD National Bancorp IN now owns 12,881 shares of the financial services provider’s stock valued at $670,000 after buying an additional 1,043 shares in the last quarter. 76.25% of the stock is owned by institutional investors.

TRADEMARK VIOLATION NOTICE: “Metlife (MET) Receives “Buy” Rating from Keefe, Bruyette & Woods” was originally reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this news story on another website, it was copied illegally and reposted in violation of United States and international trademark & copyright law. The original version of this news story can be read at https://www.dispatchtribunal.com/2018/02/24/metlife-met-receives-buy-rating-from-keefe-bruyette-woods.html.

Metlife Company Profile

MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.

Analyst Recommendations for Metlife (NYSE:MET)

Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply